Summary & Overview
HCPCS G8861: Central DXA Ordered and Osteoporosis Pharmacologic Therapy Documented
HCPCS Level II code G8861 denotes documentation that, within the prior two years, a central dual-energy x-ray absorptiometry (DXA) was ordered and recorded and that a review of systems and medication history or pharmacologic therapy (excluding minerals and vitamins) for osteoporosis was prescribed. Nationally, this code supports quality measurement and care coordination for osteoporosis screening and treatment initiation, tying diagnostic imaging orders to clinical management steps. Payers commonly interested in this documentation include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical and billing context for G8861, including the services it represents, typical sites of service, and how it is used in administrative and quality workflows. The publication provides benchmarks and policy-relevant interpretation where available, explains how G8861 interacts with clinical documentation and osteoporosis care pathways, and summarizes common uses and limitations. Data not available in the input is clearly indicated where applicable. This summary is intended for national payers, health system coders, revenue cycle professionals, and clinicians engaged in osteoporosis screening and management documentation.
Billing Code Overview
HCPCS Level II code G8861 documents that, within the past 2 years, a central dual-energy x-ray absorptiometry (DXA) scan was ordered and documented, and that a review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis was prescribed. This code captures both the diagnostic action (ordering and documenting a central DXA) and the clinical assessment or initiation of non-mineral/vitamin pharmacologic treatment for osteoporosis.
-
Service type: Osteoporosis diagnostic ordering and clinical management documentation
-
Typical site of service: Outpatient clinic or office-based setting where DXA is ordered and medication review or prescription is documented
Clinical & Coding Specifications
Clinical Context
A 68-year-old postmenopausal woman presents to her primary care clinic for a routine follow-up and preventive care visit. She has a history of fragility fracture of the wrist 3 years ago and current use of a selective serotonin reuptake inhibitor. Her clinician documents a review of systems focused on musculoskeletal symptoms (height loss, back pain), a medication history including current pharmacologic osteoporosis therapies, and orders a central dual-energy x-ray absorptiometry (DXA) of the hip and lumbar spine to assess bone mineral density. The clinician documents that a central DXA was ordered and obtained within the past 2 years and that pharmacologic therapy other than minerals/vitamins (for example, an oral bisphosphonate) was prescribed. The typical workflow includes: ordering the DXA via the outpatient imaging department; documenting indications, review of systems and medication/pharmacologic therapy in the outpatient note; receiving and reviewing the DXA report; and initiating or continuing osteoporosis pharmacologic therapy based on results and guidelines. Typical site of service is an outpatient primary care or specialty clinic with imaging performed at an outpatient radiology or densitometry center. Typical patient scenario: older adult at risk for osteoporosis receiving central DXA and pharmacologic management documented in the medical record within a 2-year period.
Coding Specifications
| Modifier | Description |
|---|